Sanofi

By 2050, there will be over two billion people aged 60 or older, making up 25% of the world’s population. On this #InternationalDayOfOlderPersons, we're reminded that as populations age and respiratory disease burden grows, #prevention against respiratory diseases through #immunization offers a powerful tool to support healthy aging, strengthen economies, and build more resilient health systems. Here's what many don't realize: a respiratory infection can go far beyond the lungs, exacerbating chronic conditions and triggering heart attacks, strokes, and cognitive or functional decline in older and other at-risk adults. This reality underscores why the International Federation on Ageing consensus statement advocates for integrating adult immunization within chronic disease prevention and management to help reduce the burden of respiratory infections, improve non-communicable disease outcomes, support healthier ageing, and strengthen health system sustainability. Preventing respiratory infections goes far beyond avoiding winter colds. It means reducing hospitalizations, preventing cardiovascular events, and helping older adults preserve their independence. ➡️ Read the consensus statement: http://spkl.io/60477pUPt

Today, we’re proud to announce an expansion of our long-standing global Alliance with Regeneron to add multiple next-generation, long-acting antibodies to our joint immunology portfolio. This expansion builds on our more than 20-year collaboration and represents an important step forward in our mission to improve the lives of patients worldwide. Read more here: http://spkl.io/60477pWkt

Valoramos este espacio de diálogo técnico que contribuye a fortalecer la certeza regulatoria en favor de la salud pública. Fue un gusto reunirnos con el comisionado federal Víctor Hugo Borja y sus equipos técnicos, en una sesión encabezada por François-Xavier Routhier, líder de Asuntos Regulatorios Internacionales de Sanofi, e Ignacio Saez-Torres Barroso, Director General de Sanofi México.   En Sanofi, reafirmamos nuestro compromiso de continuar colaborando con las autoridades regulatorias para fortalecer nuestra presencia en estudios clínicos y consolidar el rol de la inteligencia artificial en los procesos regulatorios para la introducción de nuevas moléculas.   Este tipo de encuentros también nos permite compartir experiencias regulatorias de otras regiones y avanzar en la digitalización como palanca para mejorar los procesos regulatorios, en beneficio de los pacientes y del sistema de salud en México.   #SanofiLatam #SomosBienestar

Kidney disease shaped Peio's childhood, but it never defined him. Today, he's still riding forward, mile after mile. Peio’s resilience and the support of the community around him reminds us why we do what we do. Learn more about how we’re chasing the miracles of science so people like Peio can chase their dreams: http://spkl.io/60437TkVN #FutureOfMedicine #ScienceForLife #EmpoweredByScience #ChasingMiracles

One of the most important shifts in oncology is the move toward more precise approaches to immunotherapy. Conditional antibody technologies are designed to activate preferentially in the tumor microenvironment while limiting unwanted effects on normal tissues. In the latest episode of our Partner Spotlight series, Zandra Klippel, Therapeutic Area Head, Oncology Development at Sanofi, sits down with Peter Luo, Co-founder, CEO and President of Adagene, to discuss the potential of conditional antibodies, the role of the tumor microenvironment and how collaboration can help advance increasingly complex oncology science. Check out the full conversation to learn more: http://spkl.io/60467rn8M

🎬 Legacy isn't about looking back. It's about building what's next. Making It Real, Episode 3 is now live. Go inside Sanofi's Toronto site to see how teams are continuously preparing for the future, not with buzzwords, but with action: - Rethinking water and energy management - Enabling career mobility across the site - Driving digital transformation on the floor The insight? Lasting transformation happens when people evolve alongside the business. ▶ Watch the full episode now: http://spkl.io/60407Rkgu #ManufacturingExcellence #ContinuousImprovement #MakingItReal #SanofiStories

A prescription is just the beginning. Patients often face unanswered questions, complex administrative processes, and delays in accessing support, even after that critical moment. This is where digital and AI step in. Not to replace care, but to simplify it. At Sanofi, we're rethinking the patient journey in phases: - Surface signals and risks earlier - Anticipating obstacles and connect information - Enabling smarter, faster decisions The goal is a more connected healthcare system that works better, for the people living through it, from patients to the teams supporting them. Discover how digital and AI are transforming patient care at every step: http://spkl.io/60497ucEt #AIinHealthcare #PatientCare #DigitalHealth #HealthTech

🎬 Legacy is not a contradiction. It's a continuity. What does that mean for a biopharma manufacturing site? At Sanofi's Toronto site, transformation is a continuous journey. It means building more than a century of expertise while never standing still on what's next. ➡️ See it in action: Making it Real Episode 3 live September 9, 2026. #ManufacturingExcellence #ContinuousImprovement #MakingItReal #SanofiStories

Did you know that in autoimmune type 1 diabetes, a confused immune system attacks insulin-producing cells? See how we’re chasing the miracles of science in #aT1D: http://spkl.io/60407uG5j #aT1D #PatientFirst #ChasingMiracles

Today, we’re proud to welcome Sanofi’s new Executive Committee, led by Belén Garijo. A team bringing together diverse expertise and experiences, united by a shared vision for what comes next. 🟣 Manuela Buxo, EVP, Head of Specialty Care 🟣 Paulo Fontoura, EVP, Head of Research and Development 🟣 Thomas Grenier, EVP, General Medicines 🟣 Jamie Haney, EVP, General Counsel 🟣 Veronique JAILLET, Interim Chief People Officer 🟣 Brendan O'Callaghan, EVP, Manufacturing and Supply 🟣 François-Xavier Roger, EVP, Chief Financial Officer 🟣 Thomas Triomphe, EVP, Vaccines This marks the beginning of a new chapter. And there’s plenty more to discover along the way. Welcome to our new Executive Committee! Learn more about the team: http://spkl.io/60477uHuU